Pular para o conteúdo
Tumor tritão maligno
ORPHA:252212CID-10 · C47.9CID-11 · XH2VV8DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Início todas idades
Também conhecida comoMPNSTMTT
Sinônimos clínicos: MPNST com diferenciação rabdomiossarcomatosa · MTT · Tumor maligno da bainha dos nervos periféricos com diferenciação rabdomiossarcomatosa

O tumor maligno de Triton (MTT) é um subtipo raro e agressivo de tumor maligno da bainha dos nervos periféricos (MPNST), caracterizado histopatologicamente por diferenciação rabdomioblástica focal.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

O tumor tritão maligno é um tipo raro e agressivo de câncer que atinge a camada que envolve os nervos periféricos. Ele é caracterizado por misturar elementos celulares comuns a tumores de nervos com diferenciação de tecido muscular sob o microscópio. A doença pode se manifestar em pessoas de todas as idades e surgir como uma massa em diferentes partes do corpo. No Brasil, a condição não tem um PCDT específico do Ministério da Saúde, sendo acompanhada diretamente pela rede de atenção oncológica do SUS.

📋
Informacoes curadas por IA — podem conter imprecisoes

O tumor maligno de Triton (MTT) é um subtipo raro e agressivo de tumor maligno da bainha dos nervos periféricos (MPNST), caracterizado histopatologicamente por diferenciação rabdomioblástica focal.

Publicações científicas
166 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
170
pacientes catalogados
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C47.9
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico166PubMed
Últimos 10 anos73publicações
Pico202412 papers
Linha do tempo
2026Hoje · 2026🧪 2017Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição.

HTRA1Serine protease HTRA1Part of a fusion gene inTolerante
VIAS BIOLÓGICAS (1)
Degradation of the extracellular matrix
EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
810.7 TPM
Ovário
602.0 TPM
Cervix Ectocervix
551.9 TPM
Fibroblastos
518.4 TPM
Artéria tibial
426.1 TPM
OUTRAS DOENÇAS (5)
cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2CARASIL syndromemalignant perineuriomaHTRA1-related autosomal dominant cerebral small vessel disease
HGNC:9476UniProt:Q92743
SH3PXD2ASH3 and PX domain-containing protein 2APart of a fusion gene inAltamente restrito
VIAS BIOLÓGICAS (2)
Invadopodia formationCDC42 GTPase cycle
EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
133.9 TPM
Nervo tibial
122.7 TPM
Cervix Endocervix
116.5 TPM
Útero
90.9 TPM
Fibroblastos
75.5 TPM
OUTRAS DOENÇAS (2)
malignant triton tumormalignant perineurioma
HGNC:23664UniProt:Q5TCZ1

Variantes genéticas (ClinVar)

160 variantes patogênicas registradas no ClinVar.

🧬 SH3PXD2A: NM_001394015.1(SH3PXD2A):c.229+121A>G ()
🧬 SH3PXD2A: NM_001394015.1(SH3PXD2A):c.803-3C>G ()
🧬 SH3PXD2A: GRCh37/hg19 10q23.1-25.1(chr10:87456174-107789979)x3 ()
🧬 SH3PXD2A: GRCh37/hg19 10q23.33-26.3(chr10:95078198-135427143)x3 ()
🧬 SH3PXD2A: GRCh37/hg19 10p14-q26.3(chr10:11138692-135427143) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

3 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Tumor tritão maligno

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Nenhum país com ensaio aberto no momento.

Pesquisa e ensaios clínicos

1 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
76 papers (10 anos)
#1

Heterologous Rhabdomyoblastic Differentiation in Dedifferentiated Liposarcoma Is Significantly Associated With Loss of H3K27 Trimethylation.

Pathology international2026 Mar

We identified that H3K27me3 loss appears to be a recurrent event underlying tumor dedifferentiation and heterologous rhabdomyoblastic differentiation in dedifferentiated liposarcoma. Therefore, the loss of H3K27me3 by itself does not provide definitive evidence of malignant peripheral nerve sheath tumor or malignant triton tumor when the morphology and clinical presentation of the tumor align with dedifferentiated liposarcoma.

#2

Malignant triton tumor of the common bile duct.

Clinical journal of gastroenterology2025 Oct

Malignant triton tumor (MTT) is a rare subset (5%) of malignant peripheral nerve sheath tumors (MPNSTs), classified as soft-tissue sarcomas. MTT is an orphan disease characterized by rhabdomyoblastic differentiation, therapeutic resistance, and a sinister prognosis. The neoplasms classically arise at the trunk, head and neck region, and extremities. In 50% of the cases, MTT is associated with neurofibromatosis type 1 (NF1), a relatively common autosomal dominant cancer-prone disorder of the central nervous system. Few cases of MTT in the gastrointestinal tract have been published, including esophagus, duodenum, and rectum. In this article, we present what we believe to be the first report of MTT in the common bile duct. A multidisciplinary approach was the key in establishing this particular diagnosis, and workup included endoscopic ultrasound, endoscopic retrograde cholangiopancreatography, pathological staining, and genetic testing. Literature focusing on MTT remains scarce, and patients with MTT are often included with other subtypes in broader studies of MPNST. Therefore, our literature review covers MPNST and focusses on MTT where appropriate. It provides the current understanding of tumor epidemiology, genetics, and diagnostic workup, and discusses therapeutic challenges and future perspectives. Our case report underlines the value of cholangioscopy-guided biopsies, and honoring patient's autonomy in end-of-life setting.

#3

Pathological and Immunohistochemical Features of Malignant Peripheral Nerve Sheath Tumor With Heterologous Rhabdomy Oblastic Differentiation (Malignant Triton Tumor) in the Context of the Malignant Peripheral Nerve Sheath Tumor Spectrum.

International journal of surgical pathology2025 Dec 17

Malignant peripheral nerve sheath tumors (MPNST) are aggressive sarcomas arising from Schwann cells or neurofibromas, comprising ∼10% of soft tissue sarcomas. Found in 8% to 13% of neurofibromatosis type 1 patients, they typically show spindle cells expressing S100 and SOX10. Some display heterologous differentiation (bone, cartilage, vessels, or glands). When rhabdomyosarcomatous features are present, they are called malignant peripheral nerve heath tumor with heterologous rhabdomyoblastic differentiation (malignant triton tumors), which are more prone to recurrence, metastasis, and worse outcomes. Epithelial differentiation does not affect prognosis. Despite advances in understanding MPNST biology, many pathophysiological mechanisms remain unclear. This review highlights their histopathology, focusing on malignant triton tumor.

#4

Imaging Progress and Treatment of Malignant Triton Tumor of the Skull Base.

The Journal of craniofacial surgery2025 Oct 24

Reporting the clinical course and management of a skull base malignant triton tumor in a child. An 11-year-old female patient initially presented at the age of 7 with left parotid gland swelling, exhibiting symptoms similar to parotitis. Magnetic resonance imaging (MRI) of the head performed at an external hospital suggested a neoplastic lesion in the left parotid gland and the left parasellar region. Six months later, a parotid gland biopsy was conducted. Postoperative pathology confirmed the diagnosis of embryonal rhabdomyosarcoma. Following the biopsy, the patient underwent one year of radiotherapy and chemotherapy. A follow-up head MRI examination revealed that the lesions in the parotid gland and the left parasellar region had completely resolved. The patient did not adhere to a regular schedule of follow-up examinations. At the age of 10, a follow-up head MRI revealed recurrence of the lesions in the left parotid gland and the left parasellar region. The patient subsequently underwent resection of the left parotid gland lesion at an external hospital. Postoperative pathologic analysis once again indicated embryonal rhabdomyosarcoma. The patient underwent genetic testing, which revealed a germline pathogenic mutation: NF1 p.L952Ffs*2, suggesting an inherited form of NF1. Chemotherapy was subsequently continued. A follow-up MRI performed 5 months after the second surgery showed no recurrence of the left parotid gland lesion; however, the left parasellar region lesion remained unchanged in size. A follow-up head MRI at 9 months postsecond surgery indicated an increase in the size of the left parasellar region tumor. By 10 months postsecond surgery, a follow-up head MRI showed a reduction in the left parasellar region lesion, with no recurrence of the left parotid gland lesion, leading to the discontinuation of chemotherapy. At 14 months postsecond surgery, a follow-up MRI revealed an enlargement of the left parasellar region lesion. The patient received 2 courses of chemotherapy, but a subsequent MRI showed continued growth of the left parasellar region lesion, accompanied by abnormal enhancement of the parotid gland lesion. The patient was then transferred to our department, where they underwent a left temporo-occipital craniotomy for tumor resection. Postoperative pathologic examination confirmed the diagnosis of a malignant triton tumor. Molecular pathologic testing was also performed. The patient recovered well and was discharged successfully. The patient died from cachexia caused by widespread dissemination of the parotid tumor 4 months after discharge. Pediatric skull base malignant triton tumors lack specific imaging manifestations. Radiotherapy and pharmacotherapy are insufficient to control tumor growth. Surgical resection remains the primary treatment method, yet the overall prognosis is poor.

#5

Malignant triton tumor of the bladder with fatal outcome: a rare case report.

Journal of surgical case reports2025 Sep

Malignant triton tumors (MTTs) are a rare subtype of malignant peripheral nerve sheath tumors characterized by rhabdomyoblastic differentiation, often associated with neurofibromatosis type 1 (NF-1). Primary MTTs of the bladder are exceptionally uncommon, with few documented cases. We report a case of a 75-year-old male without neurofibromatosis type 1 history presenting with hematuria and urinary obstruction. Imaging revealed a 6.5 × 4 × 2 cm invasive bladder mass, and histopathology confirmed a high-grade spindle cell neoplasm with biphasic neurogenic (S100-positive) and rhabdomyoblastic (desmin- and myogenin-positive) differentiation, consistent with a diagnosis of MTT. Despite radical cystoprostatectomy, the patient succumbed to postoperative complications. This case highlights the aggressive behavior, diagnostic challenges, and poor prognosis of bladder MTTs, emphasizing the critical role of immunohistochemistry in distinguishing them from other spindle cell neoplasms. The rarity of this presentation underscores the need for further research to elucidate its pathogenesis and optimize therapeutic strategies.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC128 artigos no totalmostrando 73

2026

Heterologous Rhabdomyoblastic Differentiation in Dedifferentiated Liposarcoma Is Significantly Associated With Loss of H3K27 Trimethylation.

Pathology international
2025

Pathological and Immunohistochemical Features of Malignant Peripheral Nerve Sheath Tumor With Heterologous Rhabdomy Oblastic Differentiation (Malignant Triton Tumor) in the Context of the Malignant Peripheral Nerve Sheath Tumor Spectrum.

International journal of surgical pathology
2025

Imaging Progress and Treatment of Malignant Triton Tumor of the Skull Base.

The Journal of craniofacial surgery
2025

Malignant triton tumor of the bladder with fatal outcome: a rare case report.

Journal of surgical case reports
2025

Malignant triton tumor of the common bile duct.

Clinical journal of gastroenterology
2025

Malignant peripheral nerve sheath tumor in early childhood: a case report of a diagnostic challenge.

Frontiers in oncology
2025

Malignant Triton Tumor of the Ileocolic Mesentery with Neurofibromatosis Type 1: A Case Report and Literature Review.

Surgical case reports
2025

Advanced Metastatic Malignant Triton Tumor in Neurofibromatosis Type 1: A Case Report and Management Challenges.

Cancer diagnosis &amp; prognosis
2025

Malignant Transformation of a Vestibular Schwannoma Without Previous Radiation Exposure: Illustrative Case and Literature Review.

Journal of neurological surgery reports
2025

Loss of H3K27me3 Is Not Specific to Malignant Triton Tumor: Immunohistochemical Analysis of 23 Cases of Embryonal Rhabdomyosarcoma.

Archives of pathology &amp; laboratory medicine
2025

Difficulties in the diagnosis and treatment of axillary malignant triton tumors: A case report.

Oncology letters
2024

Malignant Triton Tumor of the Distal Femur: A Case Report and Review of the Literature.

In vivo (Athens, Greece)
2024

A Rare Case of Malignant Triton Tumor Without Associated Neurofibromatosis.

Cureus
2024

Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma.

Genes, chromosomes &amp; cancer
2024

NF1-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of NF1-Mutant Rhabdomyosarcoma and NF1-Associated Malignant Triton Tumor.

JCO precision oncology
2024

Malignant triton tumor in the abdominal wall: A case report.

World journal of clinical cases
2024

Granulomatous Myocarditis Caused by Candida Spp Infection in a Spontaneously Diabetic Torii Rat.

Medical archives (Sarajevo, Bosnia and Herzegovina)
2024

Sporadic Malignant Triton Tumor of Shoulder: a Case Report.

Medical archives (Sarajevo, Bosnia and Herzegovina)
2024

Primary hepatic malignant triton tumor mimicking hepatocellular carcinoma by demonstrating arterial-phase hypervascularity and subsequent washout on dynamic contrast-enhanced imaging: a case report and literature review.

Frontiers in medicine
2024

A rare case of malignant triton tumor in the common peroneal nerve.

The American journal of the medical sciences
2024

Malignant "triton" tumor of the lower extremity with a history of fracture.

Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia
2024

Malignant triton tumor of uterus: A case report and literature review.

Journal of clinical ultrasound : JCU
2023

Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review.

World journal of surgical oncology
2023

Clinical diagnostic and radiographic features of recurrent intracranial malignant triton tumor in an adult: illustrative case.

Journal of neurosurgery. Case lessons
2024

Recurrent sporadic malignant triton tumor in the carotid sheath in the absence of neurofibromatosis.

The neuroradiology journal
2022

'Triton' Tumor of the Lower Alveolus: An Aggressive Variant of Malignant Peripheral Nerve Sheath Tumour.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2022

Case report: Concurrent malignant triton tumor and relapsed pituitary adenoma in the sellar region.

Frontiers in surgery
2022

How to Treat Metastatic Malignant Triton Tumor in an Adolescent.

Oncology (Williston Park, N.Y.)
2022

Case report: Primary intracranial EWs/PNET in adults: Clinical experience and literature review.

Frontiers in oncology
2022

Computed tomography imaging features of malignant 'triton' tumor to facilitate its clinical diagnosis: report of two cases.

BMC medical imaging
2022

Malignant Triton tumor of the retroperitoneum in a male unaffected by neurofibromatosis 1: A case report and literature review.

Asian journal of surgery
2022

Liver metastasis 13 years after the resection of a malignant triton tumor originating in the duodenum.

International cancer conference journal
2021

Carotid artery ligation via sternotomy as a palliative surgery: Case report of advanced intramediastinal malignant soft tissue tumor.

Clinical case reports
2021

Clinicopathological and prognostic significance of H3K27 methylation status in malignant peripheral nerve sheath tumor: correlation with skeletal muscle differentiation.

Virchows Archiv : an international journal of pathology
2021

Malignant triton tumor of the kidney in a child: A case report.

International journal of surgery case reports
2021

A Rare Case of Progressive Malignant Triton Tumor With Rare Somatic Mutation in TSC2 Gene.

Anticancer research
2021

Malignant triton tumor of the anterior mediastinum: a rare tumor in a rare location.

Radiology case reports
2021

Malignant Glandular Triton Tumor Arising in the Radial Nerve with Prolonged Survival: A Case Report and Review of the Literature.

Case reports in pathology
2021

Loss of H3K27me3 occurs in a large subset of embryonal rhabdomyosarcomas: Immunohistochemical and molecular analysis of 25 cases.

Annals of diagnostic pathology
2020

Malignant triton tumor of the rectum - A case report and review of the literature.

International journal of surgery case reports
2020

Retroperitoneal malignant triton tumor in an infant: a case report and literature review.

Translational pediatrics
2020

Elbow flexion reconstruction after arm-sparing excision for high-grade triton sarcoma: a case report.

Journal of medical case reports
2020

Malignant triton tumor below the peritoneal reflection: a case report.

Journal of surgical case reports
2020

[Focus on oncologic safety and function: Primary defect reconstruction of a malignant Triton tumor of the sciatic nerve sheath with myocutaneous free flap surgery].

Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V...
2019

Malignant Triton Tumor in a Child: Case Report and Literature Review.

Cancer management and research
2020

Triton tumor of the orbit.

Orbit (Amsterdam, Netherlands)
2019

Malignant Triton Tumor Diagnosed on Fine Needle Aspiration Cytology.

Journal of cytology
2019

Malignant triton tumor of the left thoracic cavity: a case report.

Journal of surgical case reports
2019

Mediastinal malignant triton tumor: A rare case series and review of literature.

International journal of surgery case reports
2019

A series of 10 malignant triton tumors in one institution.

Medicine
2020

Worsening Hemoptysis in a Rare Intrapulmonary Triton Tumor Mimicking Lung Cancer.

The Annals of thoracic surgery
2019

Malignant triton tumor diagnosed twelve years after radiosurgically treated vestibular schwannoma.

Clinical neurology and neurosurgery
2019

Teaching NeuroImages: Intracranial malignant triton tumor: An uncommon location of a rare tumor.

Neurology
2018

A rare case of intracranial malignant triton tumor arising in the middle cranial fossa: a case report and review of the literature.

Folia neuropathologica
2019

Expert's comment concerning Grand Rounds case entitled "Malignant triton tumor: Grand Round presentation of a rare aggressive case thoracolumbar spine tumor" by S. Ghailane et al. (Eur Spine J; 2017: DOI 10.1007/s00586-017-5277-2).

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
2018

Malignant triton tumor of the duodenum: report of a case.

International cancer conference journal
2017

[A Rare Case of Abdominal Malignant Triton Tumor].

Gan to kagaku ryoho. Cancer &amp; chemotherapy
2018

Malignant triton tumor of trigeminal nerve-case report.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2018

Malignant triton tumor of the gluteal region in a patient unaffected by neurofibromatosis: A case report.

Acta orthopaedica et traumatologica turcica
2017

A Case of Retroperitoneal Malignant Triton Tumor in a Nigerian Boy.

Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society
2019

Malignant triton tumor: Grand Round presentation of a rare aggressive case thoracolumbar spine tumor.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
2017

Malignant Triton tumor: a rare cause of sciatic pain and foot drop.

Revista brasileira de ortopedia
2016

Insidious malignant triton tumor of the chest wall with late flare-up.

Tzu chi medical journal
2017

Malignant triton tumor of the lung, infiltrating the left atrium and left ventricle, with metastasis to the small intestine.

Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery
2017

Malignant Triton Tumor (Malignant Peripheral Nerve Sheath Tumor With Rhabdomyoblastic Differentiation) Occurring in a Vascularized Free Flap Reconstruction Graft.

International journal of surgical pathology
2016

A case of recurrent malignant triton tumor successfully treated with radiotherapy.

Auris, nasus, larynx
2016

A rare case of recurrent malignant triton tumor in a male with NF1: Case report and mini-review.

International journal of surgery case reports
2015

Analysis of clinical features and prognosis of malignant triton tumor: A report of two cases and literature review.

Oncology letters
2015

Primary epididymis malignant triton tumor: case report and review of the literature.

European journal of medical research
2016

Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation.

The American journal of surgical pathology
2017

Malignant Triton Tumor of the Kidney. New Location Not Previously Reported.

Urologia internationalis
2015

Malignant Peripheral Nerve Sheath Tumor With Rhabdomyosarcomatous and Glandular Elements: Rare Epithelial Differentiation in a Triton Tumor.

International journal of surgical pathology
2015

Unusual histological variant of malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation.

World journal of clinical cases
Ver todos os 128 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Tumor tritão maligno.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Tumor tritão maligno e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

O tumor tritão maligno é um subtipo histopatológico raro e agressivo de tumor maligno da bainha dos nervos periféricos. Ele apresenta histologicamente uma diferenciação rabdomioblástica focal.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

6 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. Malignant triton tumor of the common bile duct.
    Clinical journal of gastroenterology2025PMID 40782265
  2. ORPHA:252212
    Orphanet
  3. GARD:20743
    GARD (NIH)
  4. Q6743517
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Tumor tritão maligno. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/tumor-tritao-maligno

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Tumor tritão maligno

ORPHA:252212 · MONDO:0016757
Prevalência
Unknown
Casos
170 casos conhecidos
CID-10
C47.9 · Neoplasia maligna dos nervos periféricos e sistema nervoso autônomo, não especificados
CID-11
Início
All ages
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0334616
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Rara